Public Comment

Draft guidelines for the American Society of Hematology (ASH) are made available for public comment here before society approval and publication. Typically, draft recommendations and draft evidence-to-decision frameworks are made available, but not full guideline reports.

Anyone is welcome to comment, including ASH members, non-member physicians and researchers, allied professionals, representatives of industry and insurance companies, patients, caregivers, and members of the public.

Process for Consideration of Comments Received

All comments received during the open comment period will be provided to the guideline panel for review prior to finalizing the guidelines for publication. Guideline panels are obligated to consider all comments received. Infrequently, ASH guideline panels may change judgments or decisions because of comments. More commonly, panels may provide additional explanations within the final guideline report to explain judgments or decisions. Comments may also inform ASH’s communication and implementation plan for the guidelines, as well as future updates or revisions of the guidelines. ASH will not typically provide individualized responses to comments. Individuals and organizationsnal that provide comments will not typically be identified by name within the final published guidelines. Learn more about ASH's clinical practice guidelines. 

Questions?

Please contact [email protected] with inquiries related to the public comment period.